Valuation: Jamjoom Pharmaceuticals Factory Company

Market Cap 9.58B 2.55B 2.22B 2.06B 1.89B 3.58B 243B 3.63B 24.32B 9.54B 121B 9.37B 406B P/E 2026 *
18.4x
P/E 2027 * -
Enterprise Value 9.26B 2.47B 2.14B 1.99B 1.83B 3.46B 235B 3.51B 23.51B 9.23B 117B 9.06B 393B EV / Sales 2026 *
5.73x
EV / Sales 2027 * 4.9x
Free-Float
38.61%
Yield 2026 *
3.27%
Yield 2027 * 3.64%

Last Transcript: Jamjoom Pharmaceuticals Factory Company

1 day-0.80%
1 week-3.93%
1 month-11.74%
3 months-11.97%
6 months-2.43%
Current year-3.87%
1 week 136.7
Extreme 136.7
142.4
1 month 136.7
Extreme 136.7
157
Current year 125
Extreme 125
163.7
1 year 125
Extreme 125
167
3 years 100.2
Extreme 100.2
202.4
5 years 66
Extreme 66
202.4
10 years 66
Extreme 66
202.4
Manager TitleAgeSince
Chief Executive Officer 62 2021-05-14
Director of Finance/CFO 62 2013-01-12
Chief Operating Officer 31 2021-08-31
Director TitleAgeSince
Chairman 66 2022-06-18
Director/Board Member 41 2022-06-18
Director/Board Member 98 2022-06-18
Change 5-day change 1-year change 3-year change Capi.($)
-0.80%-3.93%-15.71%+13.81% 2.55B
-0.53%+2.54%+16.63%+74.09% 50.03B
-1.81%-0.49%+51.99%+112.44% 36.6B
+0.46%+4.44%-5.24%+25.38% 12.47B
+1.05%+1.63%+16.19%+78.22% 11.77B
-1.33%-0.76%+30.08%+131.70% 9.04B
-2.99%-2.09%+41.02%-8.36% 7.03B
+0.51%+1.46%+12.17%+32.88% 6.79B
-.--%+0.14% - - 6.79B
+1.99%+1.91%+4.68%+183.54% 6.6B
Average -0.35%+0.50%+16.87%+71.52% 14.97B
Weighted average by Cap. -0.62%+1.18%+24.45%+81.61%

Financials

2026 *2027 *
Net sales 1.62B 431M 374M 348M 320M 604M 41.1B 613M 4.11B 1.61B 20.46B 1.58B 68.61B 1.87B 498M 433M 403M 370M 699M 47.56B 710M 4.75B 1.86B 23.68B 1.83B 79.39B
Net income 521M 139M 121M 112M 103M 195M 13.24B 198M 1.32B 519M 6.59B 510M 22.11B -
Net Debt -317M -84.41M -73.38M -68.3M -62.7M -118M -8.06B -120M -805M -316M -4.01B -310M -13.45B -404M -108M -93.51M -87.04M -79.91M -151M -10.27B -153M -1.03B -403M -5.11B -395M -17.14B
Logo Jamjoom Pharmaceuticals Factory Company
Jamjoom Pharmaceuticals Factory Company SJSC is a Saudi Arabia-based pharmaceutical company, which is primarily focused on developing, manufacturing, and distributing generic pharmaceuticals, cosmetics, and consumer healthcare products. It produces human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhoea, vomiting, and ulcer and acidity, among others. It operates in two segments: The Pharmaceutical products that represents medicines or drugs for the prevention and treatment of diseases, and protection of public health; and The Consumer health products that represents products used to support personal well-being, maintain health, or address specific health-related needs. The Company’s subsidiaries include Al Jamjoom Pharma for Pharmaceutical Industries and Jamjoom Pharmaceutical Industry and Commerce Company Limited and the Company also operates approximately 8 branches.
Employees
-
Date Price Change Volume
26-07-30 SAR 136.80 -0.80% 48,288
26-07-29 SAR 137.90 -2.34% 19,086
26-07-28 SAR 141.20 +1.95% 33,857
26-07-27 SAR 138.50 -0.29% 31,079
26-07-26 SAR 138.90 -2.46% 30,360
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
136.80SAR
Average target price
164.24SAR
Spread / Average Target
+20.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4015 Stock